BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 12189722)

  • 1. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
    Mazda O
    Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
    He J; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
    Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
    Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
    Iwai M; Harada Y; Tanaka S; Muramatsu A; Mori T; Kashima K; Imanishi J; Mazda O
    Biochem Biophys Res Commun; 2002 Feb; 291(1):48-54. PubMed ID: 11829460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
    Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
    Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
    Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo.
    Nakanishi H; Mazda O; Satoh E; Asada H; Morioka H; Kishida T; Nakao M; Mizutani Y; Kawauchi A; Kita M; Imanishi J; Miki T
    Gene Ther; 2003 Mar; 10(5):434-42. PubMed ID: 12601398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
    Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
    Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.
    Zuo Y; Wu J; Xu Z; Yang S; Yan H; Tan L; Meng X; Ying X; Liu R; Kang T; Huang W
    PLoS One; 2011 May; 6(5):e19407. PubMed ID: 21573215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
    Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
    J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
    Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
    Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells.
    Tomiyasu K; Satoh E; Oda Y; Nishizaki K; Kondo M; Imanishi J; Mazda O
    Biochem Biophys Res Commun; 1998 Dec; 253(3):733-8. PubMed ID: 9918796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
    Wendelburg BJ; Vos JM
    Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors.
    Howden SE; Wardan H; Voullaire L; McLenachan S; Williamson R; Ioannou P; Vadolas J
    Hum Gene Ther; 2006 Aug; 17(8):833-44. PubMed ID: 16942443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
    Judde JG; Spangler G; Magrath I; Bhatia K
    Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.